Conflict of Interest Disclosure in Oncology: Preliminary Insights From the Global ONCOTRUST-1 Cross-Sectional Study
In: JCO Global Oncology, Jg. 10 (2024-06-01), Heft 10
Online
academicJournal
Zugriff:
PURPOSEConflicts of interest (COIs) between oncologists and industry might considerably influence how the presentation of the research results is delivered, ultimately affecting clinical decisions and policy-making. Although there are many regulations on reporting COI in high-income countries (HICs), little is known about their reporting in low- and middle-income countries (LMICs). Oncology Transparency Under Scrutiny and Tracking (ONCOTRUST-1) is a pilot global survey to explore the knowledge and perceptions of oncologists regarding COI.MATERIALS AND METHODSWe designed an online 27-question–based survey in the English language to explore the perceptions and knowledge of oncologists regarding COI, with an emphasis on LMICs. Descriptive statistics and the Consensus-Based Checklist for Reporting of Survey Studies guidelines were used to report the findings.RESULTSONCOTRUST-1 surveyed 200 oncologists, 70.9% of them practicing in LMICs. Median age of the respondents was 36 (range, 26-84) years; 47.5% of them were women. Of the respondents, 40.5% reported weekly visits by pharmaceutical representatives to their institutions. Regarding oncologists' perceptions of COI that require disclosure, direct financial benefits, such as honoraria, ranked highest (58.5%), followed by gifts from pharmaceutical representatives (50%) and travel grants for attending conferences (44.5%). By contrast, personal or institutional research funding, sample drugs, consulting or advisory board, expert testimony, and food and beverage funded by pharmaceutical industry were less frequently considered as COI. Moreover, only 24% of surveyed oncologists could correctly categorize all situations representing a COI.CONCLUSIONThese findings underscore the importance of clear guidelines, education, and transparency in reporting COI in oncology. This hypothesis-generating pilot survey provided the rationale for ONCOTRUST-2 study, which will compare perceptions of COI among oncologists in LMICs and HICs.
Titel: |
Conflict of Interest Disclosure in Oncology: Preliminary Insights From the Global ONCOTRUST-1 Cross-Sectional Study
|
---|---|
Autor/in / Beteiligte Person: | Khalid El Bairi ; Najem, Salma ; Arman Reza Chowdhury ; Omar, Abeid ; Abdihamid, Omar ; Teuwen, Laure-Anne ; Benhima, Nada ; Madariaga, Ainhoa ; Elkefi, Safa ; Fernando Cristobal Diaz ; Hussain, Sadaqat ; Jenei, Kristina ; Hammad, Nazik ; Mutebi, Miriam ; Rubagumya, Fidel ; Trapani, Dario ; Nadia El Kadmiri ; Laouali, Nasser ; Fourtassi, Maryam |
Link: | |
Zeitschrift: | JCO Global Oncology, Jg. 10 (2024-06-01), Heft 10 |
Veröffentlichung: | American Society of Clinical Oncology, 2024 |
Medientyp: | academicJournal |
ISSN: | 2687-8941 (print) |
DOI: | 10.1200/GO.24.00167 |
Schlagwort: |
|
Sonstiges: |
|